FGF19 and metabolic dysfunction-associated steatotic liver disease: Our group and others have shown that serum levels of FGF-19 rise significantly 4h after oral lipid ingestion [20] and this response is blunted in patients with non-alcoholic fatty liver disease and insulin resistance [24].